Charity C. Fox

1.6k total citations
28 papers, 1.3k citations indexed

About

Charity C. Fox is a scholar working on Immunology, Physiology and Molecular Biology. According to data from OpenAlex, Charity C. Fox has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 11 papers in Physiology and 7 papers in Molecular Biology. Recurrent topics in Charity C. Fox's work include Mast cells and histamine (16 papers), Asthma and respiratory diseases (10 papers) and Immune Cell Function and Interaction (8 papers). Charity C. Fox is often cited by papers focused on Mast cells and histamine (16 papers), Asthma and respiratory diseases (10 papers) and Immune Cell Function and Interaction (8 papers). Charity C. Fox collaborates with scholars based in United States, Italy and Canada. Charity C. Fox's co-authors include L M Lichtenstein, Wendy C. Moore, Anne Kagey‐Sobotka, Duck‐Hee Kang, Lawrence M. Lichtenstein, Robert P. Schleimer, Caroline C. Whitacre, Scott D. Jewell, Lawrence M. Lichtenstein and Stephen P. Peters and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

Charity C. Fox

26 papers receiving 1.2k citations

Peers

Charity C. Fox
Ted T. Kung United States
Riccardo Sibilano United States
B. Tancowny United States
Susan M. MacDonald United States
I M Richards United States
Isao Ohno Japan
I Yaron Israel
Jamie Sturgill United States
Ted T. Kung United States
Charity C. Fox
Citations per year, relative to Charity C. Fox Charity C. Fox (= 1×) peers Ted T. Kung

Countries citing papers authored by Charity C. Fox

Since Specialization
Citations

This map shows the geographic impact of Charity C. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charity C. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charity C. Fox more than expected).

Fields of papers citing papers by Charity C. Fox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charity C. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charity C. Fox. The network helps show where Charity C. Fox may publish in the future.

Co-authorship network of co-authors of Charity C. Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Charity C. Fox. A scholar is included among the top collaborators of Charity C. Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charity C. Fox. Charity C. Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weiler, Catherine R., K. Frank Austen, Cem Akin, et al.. (2019). AAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (MCAS) diagnosis and management. Journal of Allergy and Clinical Immunology. 144(4). 883–896. 68 indexed citations
2.
Peters, Stephen P., Robert P. Schleimer, Robert M. Naclerio, et al.. (2015). The Pathophysiology of Human Mast Cells. American Review of Respiratory Disease.
3.
Curtis, Casey & Charity C. Fox. (2015). Treatment of adult hyper-IgD syndrome with canakinumab. The Journal of Allergy and Clinical Immunology In Practice. 3(5). 817–818. 7 indexed citations
4.
Crouser, Elliott D., et al.. (2010). The CD4+ Lymphopenic Sarcoidosis Phenotype Is Highly Responsive to Anti-Tumor Necrosis Factor-α Therapy. CHEST Journal. 137(6). 1432–1435. 44 indexed citations
5.
Ezzie, Michael E., William J. Janssen, James M. O’Brien, Charity C. Fox, & Marvin I. Schwarz. (2008). Failure to Respond. New England Journal of Medicine. 358(1). 70–74. 19 indexed citations
6.
Kang, Duck‐Hee & Charity C. Fox. (2001). Th1 and Th2 cytokine responses to academic stress. Research in Nursing & Health. 24(4). 245–257. 67 indexed citations
7.
Kang, Duck-Hee & Charity C. Fox. (2000). Neuroendocrine and leukocyte responses and pulmonary function to acute stressors. Annals of Behavioral Medicine. 22(4). 276–285. 31 indexed citations
8.
Beiqing, Liu, et al.. (1999). Age-related defects in Th1 and Th2 cytokine production by human T cells can be dissociated from altered frequencies of CD45RA+ and CD45RO+ T cell subsets. Mechanisms of Ageing and Development. 109(2). 97–112. 46 indexed citations
9.
Whisler, Ronald L., et al.. (1998). Phosphorylation and coupling of ζ-chains to activated T-cell receptor (TCR)/CD3 complexes from peripheral blood T-cells of elderly humans. Mechanisms of Ageing and Development. 105(1-2). 115–135. 17 indexed citations
10.
Essayan, David M., Charity C. Fox, Francesca Levi‐Schaffer, Rafeul Alam, & Lanny J. Rosenwasser. (1998). Biologic activities of IL-1 and its role in human disease. Journal of Allergy and Clinical Immunology. 102(3). 344–350. 92 indexed citations
11.
Essayan, David M., Charity C. Fox, Francesca Levi‐Schaffer, et al.. (1998). The regulation of IL-12: Its role in infectious, autoimmune, and allergic diseases. Journal of Allergy and Clinical Immunology. 102(1). 11–15. 38 indexed citations
12.
Cooke, Helen J., et al.. (1998). Presence of NK<sub>1</sub> receptors on a mucosal-like mast cell line, RBL-2H3 cells. Canadian Journal of Physiology and Pharmacology. 76(2). 188–193. 6 indexed citations
13.
Fox, Charity C., et al.. (1996). IFN-γ-Stimulated Enhancement of MHC Class II Antigen Expression by the Human Mast Cell Line HMC-1. Cellular Immunology. 170(1). 85–90. 39 indexed citations
14.
Fox, Charity C., Scott D. Jewell, & Caroline C. Whitacre. (1994). Rat Peritoneal Mast Cells Present Antigen to a PPD-Specific T Cell Line. Cellular Immunology. 158(1). 253–264. 91 indexed citations
15.
Fox, Charity C., L M Lichtenstein, & James K. Roche. (1993). Intestinal mast cell responses in idiopathic inflammatory bowel disease. Digestive Diseases and Sciences. 38(6). 1105–1112. 40 indexed citations
16.
Fox, Charity C., Wendy C. Moore, & Lawrence M. Lichtenstein. (1991). Modulation of mediator release from human intestinal mast cells by sulfasalazine and 5-aminosalicylic acid. Digestive Diseases and Sciences. 36(2). 179–184. 52 indexed citations
17.
Fox, Charity C., Audrey J. Lazenby, Wendy C. Moore, et al.. (1990). Enhancement of human intestinal mast cell mediator release in active ulcerative colitis. Gastroenterology. 99(1). 119–124. 103 indexed citations
18.
Cohan, Victoria L., Bradley J. Undem, Charity C. Fox, et al.. (1989). Dexamethasone Does Not Inhibit the Release of Mediators from Human Mast Cells Residing in Airway, Intestine, or Skin. American Review of Respiratory Disease. 140(4). 951–954. 80 indexed citations
19.
Fox, Charity C., et al.. (1988). Comparison of human lung and intestinal mast cells. Journal of Allergy and Clinical Immunology. 81(1). 89–94. 50 indexed citations
20.
Stevens, Richard L, Charity C. Fox, L M Lichtenstein, & K. Frank Austen. (1988). Identification of chondroitin sulfate E proteoglycans and heparin proteoglycans in the secretory granules of human lung mast cells.. Proceedings of the National Academy of Sciences. 85(7). 2284–2287. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026